HALOTECH develops, manufactures, and markets products related to SCD (Sperm Chromatin Dispersion test) technology aimed at evaluating DNA fragmentation to determine the seminal quality of samples used in assisted reproduction cycles.
It offers various products in the market to analyze DNA fragmentation of human (Halosperm) and animal (Halomax series) sperm, and has different products in development to analyze various parameters of interest in research on sperm DNA quality, as well as bacterial DNA.
The SCD technology is protected by patent, for which Halotech holds exclusive exploitation licenses.
Micaela Martelli, Director of Sectorial Solutions Telefónica
Blanca Caballero, CEO Nanological
Carolina Gago, COO IOT Lenses
María Urbano, CEO EvoEnzyme
Mª Inmaculada López, Director Compluemprende
Eduardo Díaz, Director of EBT Office Fund. Madri+d